Clinical Trial Update: Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effects of thalidomide on red blood cells in transfusion-dependent beta-thalassemia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia with Transfusion Dependence

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Blood Care Clinic | Conditions: Transfusion-dependent Beta-Thalassemia | Phase 3 | Status: COMPLETED